News

Biosenta announces significant advancements at its state-of-the-art bench scale production facility.

Biosenta has been making the innovative strides in the realm of antimicrobial biotechnology.

Biosenta Inc. announces licensing agreement

Biosenta granted to Lightweight Concrete Solutions a license to use Biosenta’s Tri-Filler® technology and get fee of C$200,000 and royalties

Discover Biosenta's exciting engagement with Oak Hill Financial, offering insight into their business and capital markets advisory services.

Biosenta announces a pivotal discovery revealed that Tri-Filler™ effectively sterilizes a wide range of microorganisms.

Biosenta will test Tri-Filler™ in plastics at AMPAK Inc. facilities with an eye to commercialization.

Biosenta will test Tri-Filler™ in plastics at AMPAK Inc. facilities with an eye to commercialization.

Biosenta Inc. announces further advances in research and development of Tri-Filler™

UoC professor taking about a solution fighting a drug-resistant fungus that has become a big issue for hospitals in the U.S. and Canada.

Biosenta Inc. announces further advances in research and development of the Tri-Filler™ particle.

Biosenta has completed termination of its joint venture agreement between the Company and 19443391 Ontario Inc and issued common shares.

Biosenta announces entering into of agreement to terminate joint venture

Biosenta Inc. announces that it has ceased negotiations with Voran Group Ventures Ltd.

Chelsey Reschke is one of 47 Canadians attending the G20 Young Entrepreneurs’ Alliance summit in Hamburg from Oct. 27 to 28.

How to mix the right ingredients for an environmentally friendly disinfectant

University of Calgary very encouraging anti-bacterial Biosenta particles for construction industry

Today, Biosenta realized its first purchase order and payment from the supply and purchase agreement with SANITIZATION 360.

On December 21, 2020 Biosenta’s U.S. licensing partner Kleen Bee Labs, LLC has secured licensing rights in Ralphs and Food 4 Less retailers.

This partnership enables the University team to research nanoparticles for use as antimicrobial filler in commercial construction materials.